Select year

2024 2023 2022 2021 2020 Earlier

shown/page

10

2020.12.16

Chipscreen and HISUN reach a strategic cooperation
Chipscreen and HISUN reach a strategic cooperation

2020.03.24

Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted
Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted

2019.12.03

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication

2019.10.09

Chipscreen and Novogene enter a strategic partnership for companion diagnostics development
Chipscreen and Novogene enter a strategic partnership for companion diagnostics development

2019.09.20

Chipscreeen Biosciences’s Original New Drug Bilessglu® (for Type 2 Diabetes): Commercialization Application Accepted
Chipscreeen Biosciences’s Original New Drug Bilessglu® (for Type 2 Diabetes): Commercialization Application Accepted

2018.05.30

Good News! CHIPSCREEN BIOSCIENCES Is Approved to Be Provincial Engineering Research Center
Good News! CHIPSCREEN BIOSCIENCES Is Approved to Be Provincial Engineering Research Center

2018.05.19

The CHIPSCREEN BIOSCIENCES was invited to participate in celebration of 40th anniversary of WHO Uppsala Monitoring Center
The CHIPSCREEN BIOSCIENCES was invited to participate in celebration of 40th anniversary of WHO Uppsala Monitoring Center

2018.04.27

Asian Pharmaceutical Organization Cooperation Conference ( APAC ) and Drug Development Alliance Working Group ( DA-EWG) visits the CHIPSCREEN BIOSCIENCES
Asian Pharmaceutical Organization Cooperation Conference ( APAC ) and Drug Development Alliance Working Group ( DA-EWG) visits the CHIPSCREEN BIOSCIENCES

2018.04.25

Master core technology and make China's own innovative medicine - Dr. Lu Xianping, the chairman of CHIPSCREEN BIOSCIENCES, won " 2017 China pharmaceutical development award for outstanding achiev
Master core technology and make China's own innovative medicine - Dr. Lu Xianping, the chairman of CHIPSCREEN BIOSCIENCES, won " 2017 China pharmaceutical development award for outstanding achiev

2018.04.12

Dr. Lu was invited to attend the first global forum of 30 Chinese scientists for innovation and transformation
Dr. Lu was invited to attend the first global forum of 30 Chinese scientists for innovation and transformation

Media contact

Media contact

（+86）0755-36993500
pr@chipscreen.com